Wanvisa Treebuphachasakul

Dr. Wanvisa Treebuphachasakul

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Clinical Laboratory
Verified
Journal Article
Closed access
WDW. Duanginta
W. Duanginta
NAN. Apiratmateekul
N. Apiratmateekul
GKGj. Kost
Gj. Kost
NTNk. Tran
Nk. Tran
KKK. Kongros
K. Kongros
WTWanvisa Treebuphachasakul
Wanvisa Treebuphachasakul
Background: Blood materials are essential for quality control and assurance of hemoglobin A1C (HbA1C) measure-ments. This study presents an optimal condition for in vitro glycation to prepare blood materials for HbA1C with desired high HbA1C content and commutable with two immunoassays.Methods: Washed erythrocytes were adjusted to a hematocrit (Hct) of 50 -55% and glycated in vitro at 37 degrees C for up to 120 hours with various concentrations of D-glucose in phosphate buffer saline to prepare blood materials for HbA1C. After glycation in each condition, glycation of blood material was inhibited and HbA1C level was moni-tored. The HbA1c in blood materials from in vitro glycation was compared in terms of stability and commutability with blood materials from other preparation methods.Results: Incubation of erythrocytes with 400 mM D-glucose for 15 hours at 37 degrees C resulted in a significant increase (p < 0.001) of HbA1c in blood materials by at least 40% with a remaining Hct between 38% to 42%. Hemoglobin A1C in blood materials was stable at 3.8 +/- 0.8 degrees C for 70 days and during transport for 3 days (temperature ranges from 8.1 to 23.5 degrees C), after inhibition by glucose concentration solution. Hemoglobin A1C values in blood materials from in vitro glycation were commutable between enzymatic and turbidimetric immunoassay.Conclusions: An optimal condition for in vitro glycation by incubation of erythrocytes with 400 mM D-glucose for 15 hours at 37 degrees C was able to generate HbA1C material with intact erythrocytes that is sufficiently stable and com-mutable between enzymatic and turbidimetric immunoassay. Therefore, this condition is suitable for the prepara-tion of blood material for HbA1C immunoassays.

1 January 2024 in Clinical Laboratory
Verified
Journal Article
Closed access
WDWanutchaya Duanginta
Wanutchaya Duanginta
NANapaporn Apiratmateekul
Napaporn Apiratmateekul
NTNam Tran
Nam Tran
JNJintana Nammoonnoy
Jintana Nammoonnoy
WTWanvisa Treebuphachasakul
Wanvisa Treebuphachasakul
Background: Hemoglobin A 1C (HbA 1C ) is used to evaluate glycemic control over a three-month period. Blood matrix -based HbA 1C materials are needed for quality control and evaluation of HbA 1C measurements. This study investigated the commutability of blood materials (BMs) and aimed to upgrade BMs for HbA 1C testing for use as proficiency test (PT) material. Methods: We measured BMs from a DM blood donor (n = 1), an in vitro glycation procedure (n = 3), and from commercial sources (n = 2) for HbA 1C in parallel with fresh unprocessed BMs (n = 3) and clinical blood samples (n = 25). Two NGSP-certified methods, including a turbidimetric and an enzymatic immunoassay, were used for HbA 1C determinations. Commutability as investigated according to CLSI EP14-Ed4 guidelines. Results: The commutable BMs exhibited a mean paired difference of 0% to 9% when compared to reference methods, whereas the non -commutable BMs represented a mean paired difference of 3% to 11%. Fresh, unprocessed BMs with a low HbA 1C of 6.0% were more commutable than BMs with a high HbA 1C . The values of HbA 1C in BMs (mean and uncertainty following ISO Guide 35 for RM production) were applied to upgrade the PT material to be used as a reference material. The relative uncertainty of BM-Ndm-1 and BM-Gcb-3 were 1 and 0.4%, respectively. Conclusions: The commutability of hemoglobin in BMs is dependent on the preparation process. Blood materials with a high HbA 1C content are usually less commutable versus materials with low HbA 1C content when prepared by the same process. Our study showed BMs can be successfully used as quality control or PT materials. (Clin. Lab. 2024;70:481-489. DOI: 10.7754/Clin.Lab.2023.230712)

13 March 2024 in Practical Laboratory Medicine
Verified
Journal Article
Open access
RWRenu Wiriyaprasit
Renu Wiriyaprasit
KMKhundaw Moonla
Khundaw Moonla
NANapaporn Apiratmateekul
Napaporn Apiratmateekul
ACAnchalee Chittamma
Anchalee Chittamma
GKGerald J. Kost
Gerald J. Kost
WTWanvisa Treebuphachasakul
Wanvisa Treebuphachasakul
Objectives: The objectives were to evaluate blood additives that combined lithium heparin (LH)-salt with glyceraldehyde (GLY) or d-mannose (MAN) for preserving glucose levels in plasma samples and to simultaneously determine the compatibility of these additives with 14 other biochemical tests. Blood samples from 40 subjects, equally divided into healthy and diabetic groups, were collected using five different additives. The three most effective additives, LH/GLY, LH/MAN, and LH/GLY/MAN, were selected for ensuring the best preservation of glucose levels and compatibility with 14 biochemical tests. One-way analysis of variance was used to analyze the mean paired differences of glucose level and biochemical tests. Simultaneously, the clinical criteria from Johns Hopkins Hospital were used to guide the interpretation and set acceptable thresholds for measurements that exceeded the standards. The combination of 160 mmol/L GLY, 8.4 mmol/L MAN, and LH, maintained glucose levels at approximately 93.4–93.7 % for healthy subjects and 91.3–92.8% for subjects with diabetes mellitus over 8 h. The mean paired differences of glucose levels in preservation were statistically insignificant. The biases in 14 biochemical tests for LH/GLY/MAN and LH/MAN remained within the acceptable clinical criteria during the 8 h. Combining 160 mmol/L GLY, 8.4 mmol/L MAN, and LH, proved more effective in maintaining glucose levels than individual additives or the conventional sodium fluoride preservative. It did not yield clinical discrepancies in the 14 biochemical tests during 8 h at room temperature.

1 July 2025 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
TNTeonchit Nuamchit
Teonchit Nuamchit
WCWeerapong Chidnok
Weerapong Chidnok
TTTomon Thongsri
Tomon Thongsri
NRNuttanit Rodvinit
Nuttanit Rodvinit
TCThanaphon Chaitawong
Thanaphon Chaitawong
PTPiyanuch Thitiwuthikiat
Piyanuch Thitiwuthikiat
Purpose: Blood pressure (BP) response observed during exercise stress tests has been recognized as a predictor of the onset of hypertension and arterial stiffness. However, access to such testing is often limited to specialized clinical settings. The purpose of this study was to assess the utility of a simple, equipment-free exercise, self-paced spot marching exercise (SME), along with the subsequent recovery BP in evaluating vascular functions. Patients and Methods: A cross-sectional study was conducted with 107 participants aged 40– 59 years, including those with and without hypertension. During the 6-min recovery period following SME, systolic BP (SBP) and diastolic BP (DBP) were measured every 2 min. Flow-mediated dilation (FMD) and cardio-ankle vascular index (CAVI) were used to evaluate endothelial function and arterial stiffness. Pearson’s correlation and multiple linear regression analyses were performed to assess the associations between recovery BP and vascular parameters. Results: Among total participants, 4-min recovery SBP was independently associated with FMD, whereas resting BP showed no such association. CAVI was not correlated with any recovery BP. In non-hypertensive individuals, 4-min recovery SBP remained independently associated with FMD, whereas age and resting SBP were linked to CAVI. Conclusion: These findings suggest that recovery SBP following SME reflects early endothelial dysfunction and vascular impairment. Therefore, using recovery SBP after the SME demonstrates the potential to be a tool for the early detection of vascular risk in middle-aged adults.

13 September 2021 in Journal of Diabetes Science and Technology
Verified
Journal Article
Open access
PDF file
NANapaporn Apiratmateekul
Napaporn Apiratmateekul
WDWanutchaya Duanginta
Wanutchaya Duanginta
MPMethawadee Phetree
Methawadee Phetree
KKKunchit Kongros
Kunchit Kongros
WTWanvisa Treebuphachasakul
Wanvisa Treebuphachasakul
Annual peaks in temperature and humidity exceed manufacturers’ specifications for blood glucose test strip storage in Thailand. Health Promoting Hospitals (HPH) do not always provide the same level of health services that hospitals do since they often only turn on air-conditioning units during working hours. The blood glucose testing performance of 4 glucose meters were investigated for short and long terms stress at 5 simulated conditions. Temperature and relative humidity (RH) at 5 HPHs in different regions of Thailand were monitored for 9 weeks during April to July 2019. The use of air conditioning in storage rooms for storing test strips was surveyed at 131 HPHs using questionnaires. Median-paired differences of glucose measurements with stressed test strips in 5 simulated conditions significantly differed (P < 0.05) both in the short term (3 days) and in the long term (30 days) with 4 glucose meters when compared to unstressed test strips. The average temperature of all HPHs exceeded 30°C (86°F). The average RH was 84%. There was only one HPH that occasionally turned on its air conditioners. Most HPHs kept both opened and unopened vials of test strips in rooms without air conditioners. Further, 21.4-32.0% of HPHs kept test strips at room with air conditioners. This study provides evidence for poor performance of blood glucose testing by glucose meters that are affected by adverse environmental conditions. The environmental for test strips storage at HPHs should be considered to prevent analytical errors of glucose measurement.

11 April 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
NANapaporn Apiratmateekul
Napaporn Apiratmateekul
JNJintana Nammoonnoy
Jintana Nammoonnoy
Gerald J. KostGerald J. Kost
Gerald J. Kost
WTWanvisa Treebuphachasakul
Wanvisa Treebuphachasakul
Glucose meters provide a rapid blood glucose status for evidence-based diagnosis, monitoring, and treatment of diabetes mellitus. We aimed to evaluate the commutability of processed blood materials (PBMs) and their use in the performance evaluation of glucose meters. Two PBMs obtained by the fixed-cell method were analyzed for homogeneity, stability, and commutability. The compatibility of ten pairs between mass spectrometry and each glucose meter was categorized as compatible (mean paired difference ≤ 5%) and incompatible (mean paired difference > 5%). The performance of glucose meter 1 (n = 767) and glucose meter 2 (n = 266) was assessed. The glucose in the PBMs remained homogenized and stable for at least 180 days. Six out of ten pairs had commutable PBMs. Commutability of PBMs was observed in both well-compatible and incompatible glucose results. Target glucose values from mass spectrometry were significantly different (p ≤ 0.05) from consensus values in one group of glucose meters. When commutable PBMs were used, glucose meter 1 showed better performance than glucose meter 2, and the percentage of satisfaction was associated when using target values for glucose from mass spectrometry and consensus values, but the performance of glucose meter 2 was not associated. PBM from a fixed-cell method could be mass produced with acceptable homogeneity and stability. Commutability testing of PBMs is required prior to use in the performance evaluation of glucose meters, as the commutability of glucose in the PBMs obtained by a fixed-cell method was variable and depended on the individual glucose meter.